Literature DB >> 10807318

MAP kinase pathways activated by stress: the p38 MAPK pathway.

T Obata1, G E Brown, M B Yaffe.   

Abstract

A stress-activated serine/threonine protein kinase, p38 mitogen-activated protein kinase (p38 MAPK), belongs to the MAP kinase superfamily. Diverse extracellular stimuli, including ultraviolet light, irradiation, heat shock, high osmotic stress, proinflammatory cytokines and certain mitogens, trigger a stress-regulated protein kinase cascade culminating in activation of p38 MAPK through phosphorylation on a TGY motif within the kinase activation loop. p38 MAPK appears to play a major role in apoptosis, cytokine production, transcriptional regulation, and cytoskeletal reorganization, and has been causally implicated in sepsis, ischemic heart disease, arthritis, human immunodeficiency virus infection, and Alzheimer's disease. The availability of specific inhibitors helps to clarify the role that p38 MAPK plays in these processes, and may ultimately offer therapeutic benefit for certain critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807318     DOI: 10.1097/00003246-200004001-00008

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  83 in total

1.  Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers.

Authors:  J W Fijen; J G Zijlstra; P De Boer; R Spanjersberg; J W Tervaert; T S Van Der Werf; J J Ligtenberg; J E Tulleken
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte.

Authors:  Asuka Ota; Jun Zhang; Peipei Ping; Jiahuai Han; Yibin Wang
Journal:  Circ Res       Date:  2010-03-18       Impact factor: 17.367

3.  Epigallocatechin gallate inhibits angiotensin II-induced endothelial barrier dysfunction via inhibition of the p38 MAPK/HSP27 pathway.

Authors:  Dan Yang; Jing Liu; Cui Tian; Yong Zeng; Yue-hong Zheng; Quan Fang; Hui-hua Li
Journal:  Acta Pharmacol Sin       Date:  2010-07-19       Impact factor: 6.150

4.  A muscle-specific p38 MAPK/Mef2/MnSOD pathway regulates stress, motor function, and life span in Drosophila.

Authors:  Alysia Vrailas-Mortimer; Tania del Rivero; Subhas Mukherjee; Sanjay Nag; Alexandros Gaitanidis; Dimitris Kadas; Christos Consoulas; Atanu Duttaroy; Subhabrata Sanyal
Journal:  Dev Cell       Date:  2011-10-18       Impact factor: 12.270

5.  Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.

Authors:  Masashi Miyazaki; Yosuke Fujikawa; Chikahiro Takita; Hiroshi Tsumura
Journal:  Clin Rheumatol       Date:  2006-04-04       Impact factor: 2.980

Review 6.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Curr Opin Cell Biol       Date:  2009-02-21       Impact factor: 8.382

7.  TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle.

Authors:  Yi-Ping Li; Yuling Chen; Joseph John; Jennifer Moylan; Bingwen Jin; Douglas L Mann; Michael B Reid
Journal:  FASEB J       Date:  2005-03       Impact factor: 5.191

8.  Ablation of Akt2 protects against lipopolysaccharide-induced cardiac dysfunction: role of Akt ubiquitination E3 ligase TRAF6.

Authors:  Yingmei Zhang; Xihui Xu; Asli F Ceylan-Isik; Maolong Dong; Zhaohui Pei; Yan Li; Jun Ren
Journal:  J Mol Cell Cardiol       Date:  2014-05-05       Impact factor: 5.000

9.  p38 Mitogen-activated protein kinase regulates nuclear receptor CAR that activates the CYP2B6 gene.

Authors:  Kosuke Saito; Rick Moore; Masahiko Negishi
Journal:  Drug Metab Dispos       Date:  2013-03-28       Impact factor: 3.922

10.  Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma.

Authors:  Ben Davidson; Vered Givant-Horwitz; Philip Lazarovici; Björn Risberg; Jahn M Nesland; Claes G Trope; Erik Schaefer; Reuven Reich
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.